Our OB/GYN would like to begin using Reclast on patients that have not been diagnosed with osteoporosis or osteopenia but have a high fracture risk.
I would like something to back this up... anyone have any information you can share with me?
In most cases, the patients we pursue reclast in have some sort of intolerance to oral biphosphenates, or have tried them and are not improving on their bone density. We rarely recommend it prior to trying some sort of oral biphosphenate first.
What is dx for fracture risk?